Singapore markets closed

ChemoMetec A/S (0DZ0.L)

LSE - LSE Delayed price. Currency in DKK
Add to watchlist
820.00+41.50 (+5.33%)
At close: 05:53PM BST
Full screen
Previous close778.50
Open791.00
Bid0.00 x 0
Ask0.00 x 0
Day's range791.00 - 810.50
52-week range304.00 - 905.00
Volume540
Avg. volume5,187
Market cap120.703M
Beta (5Y monthly)1.20
PE ratio (TTM)1.09
EPS (TTM)7.55
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Clarification of guidance for revenue and lower than expected operating profit in the 2023/24 financial year

    ANNOUNCEMENT NO. 261 Clarification of guidance for revenue and lower than expected operating profit in the 2023/24 financial year According to the preliminary figures, revenue in the third quarter of 2023/24 was DKK 98.9 million and in the first nine months of 2023/24 DKK 298.2 million. Based on the development in the third quarter of 2023/24 and the expectations for the remaining part of the financial year, expectations for revenue for the 2023/24 financial year are clarified. Hence, revenue in

  • GlobeNewswire

    Major shareholder announcement – BlackRock, Inc.

    ANNOUNCEMENT NO. 260 Major shareholder announcement Major shareholder announcement – BlackRock, Inc. Pursuant to Section 30 of the Capital Markets Act, it is hereby announced that BlackRock, Inc. has informed ChemoMetec A/S that BlackRock Investment Management (UK) Limited on 9 April 2024, increased its holding of voting rights attached to shares and voting rights in ChemoMetec A/S to above 10%, and that the holding thus exceeds the 10 per cent limit in section 38 of the Capital Markets Act. The

  • GlobeNewswire

    Major shareholder announcement – Swedbank Robur Fonder AB

    ANNOUNCEMENT NO. 259 Major shareholder announcement Major shareholder announcement – Swedbank Robur Fonder AB Pursuant to Section 38 of the Danish Capital Markets Act, it is hereby announced that Swedbank Robur Fonder AB has informed ChemoMetec A/S that Swedbank Robur Fonder AB on 2 April 2024, decreased its holding of shares and voting rights to below 5% of the total share capital and voting rights in ChemoMetec A/S. Additional information Niels Høy Nielsen, CFOTelephone (+45) 2551 8724 About C